Company Filing History:
Years Active: 2020
Title: Innovations of Eugene Y Kym in Unnatural Amino Acid Incorporation
Introduction
Eugene Y Kym is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the incorporation of unnatural amino acids into proteins. His innovative methods have the potential to advance various applications in protein engineering and synthetic biology.
Latest Patents
Eugene Y Kym holds a patent titled "Use of eRF1 mutants in unnatural amino acid incorporation." This invention relates to a method for incorporating an unnatural amino acid into a protein of interest within a eukaryotic cell. The method involves providing a eukaryotic cell that expresses an orthogonal tRNA synthetase-tRNA pair, a nucleic acid sequence encoding the protein of interest, and a mutant eRF1. The mutant eRF1 has an amino acid sequence with at least 60% sequence identity to the human wild type eRF1 sequence. The process includes incubating the eukaryotic cell in the presence of the unnatural amino acid, allowing for its incorporation into the protein via the orthogonal tRNA synthetase-tRNA pair. This patent represents a significant advancement in the field of protein synthesis.
Career Highlights
Eugene Y Kym is affiliated with United Kingdom Research and Innovation, where he continues to explore innovative solutions in biotechnology. His work focuses on enhancing the capabilities of eukaryotic cells to incorporate unnatural amino acids, which can lead to the development of novel proteins with unique functionalities.
Collaborations
Eugene has collaborated with esteemed colleagues such as Jason W Chin and Wolfgang H Schmied. These collaborations have further enriched his research and contributed to the advancement of his innovative methods.
Conclusion
Eugene Y Kym's contributions to the field of biotechnology, particularly through his patent on unnatural amino acid incorporation, highlight his role as a leading inventor in this area. His work has the potential to significantly impact protein engineering and synthetic biology.